Reference; 2022-11-16: https://mbp-japan.com/jijico/articles/32301/
Modified and translated by CFJA
Is it possible to make use of the perspective of Eastern medicine in improving the Covid-19 sequelae?
The infectious period is considered to be from 2 days prior to the onset of illness to 14 days after the onset of illness. Recently, more and more patients are coming to our clinic around 2 weeks after the onset of Covid infection. Symptoms at that time are divided into those with symptoms that have continued for about 2 weeks since the onset of the disease and those with newly emerged symptoms which have emerged 1 to 2 weeks later after the onset. In some cases, patients may have both. Through the empirical treatment of post-Covid syndrome, we have experienced that improvement is rarely achieved in a single visit, and more frequent and repeated treatments are required compared to patients with similar symptoms without the Covid infection. However, we have definitely experienced cases in which symptoms are improved by repeated acupuncture and moxibustion treatment and cupping therapy for purifying blood.
Half of the patients with post-Covid syndrome improve with just taking rest without any treatment. On the other hand, there are those who have difficulty improving and those who continue to deteriorate even with taking rest. There was a case in which a 93 year old Japanese patient in Japan who was hospitalized for 9 days after the onset of the disease, became bedridden one week after discharge from hospital, and was ordered by his doctor to withdraw from medical treatment, regained his daily life after one month of moxibustion treatment. It may have been just a lucky case, but it is an event that makes us feel the high possibility of moxibustion treatment. If you are suffering from post-Covid syndrome, you may want to consider treatment from the perspective of eastern medicine to prevent worsening of symptoms. Our clinic also offers home visit treatment, so if you have difficulty going out, please feel free to contact us.